Calian Announces the Appointment of New President of Calian Health
Calian Group Ltd. (TSX:CGY) announced the appointment of Derek Clark as President, Health, effective early February 2023. He succeeds Gordon McDonald, who is retiring on March 30, 2023, after a distinguished career. Clark is a seasoned health executive with extensive experience at GE Healthcare and as Chief Operating Officer at Neurolign Technologies. His leadership is expected to enhance the commercialization journey and change management at Calian. CEO Kevin Ford expressed enthusiasm for Clark's strong leadership and expertise, which will support Calian Health's growth strategy.
- Derek Clark's extensive background in health technology and leadership roles is expected to drive growth in Calian Health.
- Clark's experience with commercialization and change management may provide a fresh perspective and improved strategies for the company.
- The retirement of Gordon McDonald raises concerns about continuity and potential experience gaps in leadership.
OTTAWA, ON / ACCESSWIRE / February 9, 2023 / Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, is proud to announce the appointment of Derek Clark as President, Health. He will take over the leadership of Calian Health from Gordon McDonald, who is retiring March 30, 2023, after a long and successful career in health and health services.
Mr. Clark is a seasoned health executive who has worked in a variety of companies from large multinationals, to start ups, and consulting practices. Beginning at GE Healthcare, he built his career aligning multiple business units and bringing the strength of GE's portfolio and expertise to positively impact key client relationships. Mr. Clark was later appointed the role of Chief Commercial Officer for GE Canada driving growth across all of the GE businesses. He then founded Resolve Consulting, a boutique consulting firm, where he was an executive commercialization consultant to an elite group of clients.
Most recently, Mr. Clark served as Chief Operating Officer for Neurolign Technologies, a medical device and pharma start-up focused on the diagnosis and treatment of concussions. Throughout his career, Mr. Clark has commercialized new health technologies, software, and services, successfully leading cross-business teams to win several large complex infrastructure projects through a unified deal strategy and rigorous execution.
"Derek Clark is a strong leader with a deep understanding of the multi-faceted health segment. He has a passion for teaching, mentoring and coaching leaders, a quality that we value highly here at Calian," says Kevin Ford, Calian CEO. "Derek's experience leading teams through the commercialization journey, change management and acquisitions will benefit the entire Calian Health team, and I am delighted to welcome him at such an exciting time in our growth. I would also like to thank Gordon McDonald for his years of service to Calian, leading the Calian Health team through the important transitions that have brought us to this point."
Mr. Clark will join Calian in early February 2023.
About Calian
We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives-today and tomorrow. Every day, our employees live our values of customer commitment, integrity, innovation and teamwork to engineer reliable solutions that solve complex problems. That's Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American and International markets.
Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.
Media inquiries:
pr@calian.com
613-599-8600 x 2298
Investor Relations inquiries:
ir@calian.com
DISCLAIMER
Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as "intend", "anticipate", "believe", "estimate", "expect" or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company's most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.
Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: info@calian.com
SOURCE: Calian Group Ltd.
View source version on accesswire.com:
https://www.accesswire.com/738874/Calian-Announces-the-Appointment-of-New-President-of-Calian-Health
FAQ
Who is Derek Clark and what will be his role at Calian?
When will Derek Clark officially join Calian?
What is the significance of Gordon McDonald's retirement for Calian?
What experience does Derek Clark bring to Calian Health?
What are the potential impacts of Derek Clark's appointment on Calian's stock?
